Impact of bipolar study


The IMPACT of Bipolar Study involved 700 participants aged 18-65 who had been diagnosed with bipolar I disorder for 12 months or more. The study was commissioned by Lundbeck Ltd and conducted in the UK, Spain, France, Italy, Germany, Canada and Australia by Phoenix Healthcare.1


The main objectives of the study were to investigate the impact of bipolar I disorder on people who have the condition.  This included aspects of the professional and personal lives of participants and their relationships with their partner, family and friends.1


The survey was conducted online with participants being asked to complete a 20 minute questionnaire after passing the screening stage.1

The main components of screening for inclusion were:

  • Diagnosed with bipolar I disorder for at least 12 months
  • Have experienced a period involving an increase of at least five symptoms of mania
  • Period(s) of mania have caused problems in everyday life
  • Had not experienced bipolar symptoms for at least 3 weeks
  • Be on at least one appropriate medication for bipolar I disorder


The split between male and female respondents was 45% male, 55% female.

Participants were proportionately distributed across age ranges.1

Distribution across age ranges

Show only content from:
All countries
  • All countries
  • Australia
  • Canada
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom

All countries


The IMPACT of Bipolar Study is endorsed by the Global Alliance of Mental Illness Advocacy Networks (GAMIAN). Further information about GAMIAN can be found on their website


  1. IMPACT of Bipolar Study 2012 (data on file)
Cookie Policy